GB1291281A - Improvements in pharmaceutical compositions - Google Patents

Improvements in pharmaceutical compositions

Info

Publication number
GB1291281A
GB1291281A GB04670/69A GB1467069A GB1291281A GB 1291281 A GB1291281 A GB 1291281A GB 04670/69 A GB04670/69 A GB 04670/69A GB 1467069 A GB1467069 A GB 1467069A GB 1291281 A GB1291281 A GB 1291281A
Authority
GB
United Kingdom
Prior art keywords
sodium
potassium
citrate
carbo
penicillin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB04670/69A
Other languages
English (en)
Inventor
Joseph Stanley Dwight
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd Great Britain
Pfizer Inc
Original Assignee
Pfizer Ltd Great Britain
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd Great Britain, Pfizer Inc filed Critical Pfizer Ltd Great Britain
Priority to GB04670/69A priority Critical patent/GB1291281A/en
Priority to IL34089A priority patent/IL34089A/xx
Priority to DE19702013039 priority patent/DE2013039A1/de
Priority to DK138070AA priority patent/DK128674B/da
Priority to FI700775A priority patent/FI51653C/fi
Priority to BE747656D priority patent/BE747656A/xx
Priority to FR7010069A priority patent/FR2035118B1/fr
Priority to NL707004004A priority patent/NL143419B/xx
Priority to SE7003870A priority patent/SE379284B/xx
Priority to ES377725A priority patent/ES377725A1/es
Publication of GB1291281A publication Critical patent/GB1291281A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
GB04670/69A 1969-03-20 1969-03-20 Improvements in pharmaceutical compositions Expired GB1291281A (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
GB04670/69A GB1291281A (en) 1969-03-20 1969-03-20 Improvements in pharmaceutical compositions
IL34089A IL34089A (en) 1969-03-20 1970-03-16 Pharmaceutical compositions containing penicillin or cephalosphorin derivatives
DE19702013039 DE2013039A1 (de) 1969-03-20 1970-03-19 Arzneimitteltablette zur oralen Verabreichung
DK138070AA DK128674B (da) 1969-03-20 1970-03-19 Fremgangsmåde til fremstilling af tabletter indeholdende vandopløselige salte af α-carboxyester-substituerede phenylmethyl-penicilliner eller α-carboxyester-substituerede phenylmethyl-cephalosporiner til oral indgivning.
FI700775A FI51653C (fi) 1969-03-20 1970-03-19 Menetelmä suun kautta annostettavan penisilliini- tai kefalosporiinita bletin valmistamiseksi.
BE747656D BE747656A (fr) 1969-03-20 1970-03-19 Compositions pharmaceutiques ameliorees comprenant un sel hydrosoluble d'un compose acide actif et un excipient hydrosoluble (
FR7010069A FR2035118B1 (https=) 1969-03-20 1970-03-20
NL707004004A NL143419B (nl) 1969-03-20 1970-03-20 Werkwijze voor het bereiden van een penicilline-preparaat in de vorm van een tablet door een in water oplosbaar zout van een penicilline en een in water oplosbaar buffermiddel tot een tablet te verwerken, alsmede aldus verkregen tabletten.
SE7003870A SE379284B (https=) 1969-03-20 1970-03-20
ES377725A ES377725A1 (es) 1969-03-20 1970-03-20 Un procedimiento para preparar una tableta adecuada para administracion oral.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB04670/69A GB1291281A (en) 1969-03-20 1969-03-20 Improvements in pharmaceutical compositions

Publications (1)

Publication Number Publication Date
GB1291281A true GB1291281A (en) 1972-10-04

Family

ID=10045462

Family Applications (1)

Application Number Title Priority Date Filing Date
GB04670/69A Expired GB1291281A (en) 1969-03-20 1969-03-20 Improvements in pharmaceutical compositions

Country Status (10)

Country Link
BE (1) BE747656A (https=)
DE (1) DE2013039A1 (https=)
DK (1) DK128674B (https=)
ES (1) ES377725A1 (https=)
FI (1) FI51653C (https=)
FR (1) FR2035118B1 (https=)
GB (1) GB1291281A (https=)
IL (1) IL34089A (https=)
NL (1) NL143419B (https=)
SE (1) SE379284B (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5424075A (en) * 1991-03-27 1995-06-13 Miles Inc. Delivery system for enhanced onset and increased potency

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2083622B1 (https=) * 1970-03-27 1975-08-22 Sankyo Co
US3940483A (en) 1971-02-05 1976-02-24 E. R. Squibb & Sons, Inc. Antibiotic compositions and method
US3969524A (en) * 1974-08-13 1976-07-13 Hoffmann-La Roche Inc. Stable amoxicillin dosage form
JPS5329936A (en) * 1976-08-31 1978-03-20 Takeda Chem Ind Ltd Antibiotic composition
DE2965732D1 (en) * 1978-12-08 1983-07-28 Beecham Group Plc Pharmaceutical composition comprising a water soluble salt of amoxycillin and polyvinylpyrrolidone, and a vial containing a unit dose of said composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2438106A (en) * 1944-06-09 1948-03-23 Wyeth Corp Peroral penicillin compositions
US2864744A (en) * 1955-09-02 1958-12-16 American Home Prod Penicillin in solid dosage unit form
US3131123A (en) * 1959-03-13 1964-04-28 Lab Francais De Therapeutique Enteric tablets and manufacture thereof
GB1276839A (en) * 1968-08-02 1972-06-07 Sandoz Products Ltd Antibiotic compositions

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5424075A (en) * 1991-03-27 1995-06-13 Miles Inc. Delivery system for enhanced onset and increased potency

Also Published As

Publication number Publication date
FR2035118A1 (https=) 1970-12-18
FR2035118B1 (https=) 1974-08-30
DE2013039A1 (de) 1970-09-24
SE379284B (https=) 1975-10-06
NL143419B (nl) 1974-10-15
BE747656A (fr) 1970-09-21
ES377725A1 (es) 1972-10-16
IL34089A (en) 1974-05-16
FI51653B (https=) 1976-11-30
FI51653C (fi) 1977-03-10
NL7004004A (https=) 1970-09-22
IL34089A0 (en) 1970-05-21
DK128674B (da) 1974-06-17

Similar Documents

Publication Publication Date Title
ES424533A1 (es) Metodo de prolongar la disponibilidad de sustancias farmaco-logicamente activas incluidas en composiciones farmaceuticasa base de alcohol alifatico e hidroxialcohilcelulosa.
PT91442A (pt) Forma de dosagem de libertacao controlada compreendendo diferentes eteres de celulose
SE8202172L (sv) Topiska farmaceutiska kompositioner
GB1492688A (en) Enzyme-containing denture cleanser tablet
GR3031135T3 (en) Compositions containing S(+)-Ibuprofen.
GB1274271A (en) Improvements in or relating to propionic acid derivatives
GB1270781A (en) Tableting medium
GB1291281A (en) Improvements in pharmaceutical compositions
GB1492687A (en) Water-soluble lubricant in tabletting compositions
GB1507418A (en) Process for producing tablets and suppositories and a composition for use therein
GB1274797A (en) Effervescent tablets and powders
CA2050970A1 (en) Pharmaceutical compositions containing furan derivatives
GB1464200A (en) Pharmaceutical composition
ES395533A1 (es) Un procedimiento para preparar composiciones farmaceuticas de liberacion prolongada a base de acido acetilsalicilico.
GB1291282A (en) Improvements in pharmaceutical compositions
GB1355985A (en) Solid slow release preparation of prolonged action
GB1403900A (en) Pharmaceutical composition
GB1202148A (en) Pharmaceutical compositions
GB9415048D0 (en) Tablet
GB1505738A (en) Tabletting processes
GB1248054A (en) Improvements in or relating to fire extinguishing compositions
GB1381426A (en) Method of treating mammals and composition comprising oligosaccha ride sulphuric acid esters and nonionic surface active agents
ES447712A1 (es) Un procedimiento de preparacion de una suspension de dioxi- do de titanio.
GB1139991A (en) Stabilized enzyme composition
GB1357813A (en) Effervescent composition for the treatment of heart diseases

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee